Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Five years post-surgery, those who underwent one-anastomosis gastric bypass had total body weight loss of 34.88%, those who underwent roux-en-Y gastric bypass lost 30.73%, those who had sleeve ...

Creation of the small stomach pouch and the small anastomosis for food and drugs ... or altered mesenteric blood flow. a RYGB = Roux-en-Y gastric bypass, Mct1 = monocarboxylic acid transporter ...